Endpoints News 26 janv. 2026 Sarepta touts three-year Duchenne gene therapy data after patient deaths
Endpoints News 26 janv. 2026 Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing
Endpoints News 26 janv. 2026 UK medicines agency seized 20M illegal drugs last year, including GLP-1s
Endpoints News 24 janv. 2026 First-movers respond to herding; BioMarin vets start new biotech; GSK buys RAPT Therapeutics; and more
Endpoints News 23 janv. 2026 F2G CEO outlines biotech's FDA resubmission plans, funding and expansion
Endpoints News 23 janv. 2026 Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster
Endpoints News 23 janv. 2026 Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO
Endpoints News 22 janv. 2026 High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’